Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Discontinuation of vitamin K antagonists and elastin degradation
NL-OMON45726Not yet recruiting
- Sponsor
- Canisius-Wilhelmina Hospital
- Start
- Apr 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial in Vitamin K deficiency, sponsored by Canisius-Wilhelmina Hospital. Primary endpoint: Change in elastin degradation rate. Planned start Apr 2017; status: not yet recruiting.
02
Conditions
Vitamin K deficiency
Beyond the preview
Go deeper on NL-OMON45726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45726.